Hybrigenics has extended its partnership with Servier to discover new drugs which inhibit Ubiquitin-Specific Proteases, or USPs. This partnership was initiated in October 2011.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0094 EUR | -1.05% | +3.30% | -57.66% |
06-04 | ITALY GROWTH WINNERS & LOSERS: Bullish plants; Aton Green at the back of the pack. | AN |
05-07 | ATON board of directors chooses Uguzzoni as CEO and appoints Nervosi as vice chairman | AN |
1st Jan change | Capi. | |
---|---|---|
-57.66% | 4.13M | |
+9.24% | 221B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.85B | |
+14.99% | 52.84B | |
+4.85% | 50.86B | |
-4.47% | 38.75B | |
-0.41% | 35.15B |
- Stock Market
- Equities
- ALHYG Stock
- News ATON
- Hybrigenics Extends Partnership with Servier for USPs Inhibitors